MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,664,560 | -90.3% | 290,808 | -86.0% | 0.01% | -90.6% |
| Q2 2023 | $47,999,869 | -3.5% | 2,070,745 | -3.3% | 0.11% | -14.5% |
| Q1 2023 | $49,725,604 | +9825.3% | 2,140,577 | +8056.1% | 0.12% | +6100.0% |
| Q3 2022 | $501,000 | -21.2% | 26,245 | -25.0% | 0.00% | 0.0% |
| Q2 2022 | $636,000 | -92.1% | 35,000 | -89.1% | 0.00% | -92.3% |
| Q1 2022 | $8,091,000 | +13.3% | 321,067 | +45.2% | 0.03% | -13.3% |
| Q3 2021 | $7,142,000 | +9.8% | 221,193 | +3.6% | 0.03% | -6.2% |
| Q1 2021 | $6,503,000 | -38.2% | 213,566 | -59.9% | 0.03% | -44.8% |
| Q4 2020 | $10,522,000 | +310.5% | 532,095 | +170.8% | 0.06% | +205.3% |
| Q3 2020 | $2,563,000 | +54.2% | 196,522 | +34.1% | 0.02% | +35.7% |
| Q2 2020 | $1,662,000 | +75.3% | 146,581 | +349.5% | 0.01% | +100.0% |
| Q4 2018 | $948,000 | -50.7% | 32,610 | -21.9% | 0.01% | -22.2% |
| Q3 2018 | $1,921,000 | +156.5% | 41,760 | +64.7% | 0.01% | +200.0% |
| Q1 2018 | $749,000 | +1.8% | 25,355 | +18.4% | 0.00% | +50.0% |
| Q4 2017 | $736,000 | +242.3% | 21,418 | +66.2% | 0.00% | +100.0% |
| Q4 2016 | $215,000 | – | 12,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |